Biosynthetic production of steviol glycoside rebaudioside D4 from rebaudioside E
US11306340B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2019 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Jan 15, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/22035
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates, in some aspects, to the production of steviol glycoside rebaudioside D4 through the use of rebaudioside E. In some aspects, the invention relates to mutant CP1 enzymes, mutant HV1 enzymes as well as host cells and methods utilizing such enzymes, such as to produce rebaudioside D4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.